Laddar...
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
Tumors have developed multiple immunosuppressive mechanisms to turn down the innate and the effector arms of the immune system, thus compromising most of the immunotherapeutic strategies that have been proposed during the last decade. Right after the pioneering success of Ipilimumab (anti-CTLA4) in...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Landes Bioscience
2012
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3518493/ https://ncbi.nlm.nih.gov/pubmed/23243584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.21335 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|